XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.bigmoleculewatch.com/2017/07/31/sandoz-pushes-back-pegfilgrastim-u-s-resubmission-target-date/20%Monthly2018-01-08 18:41
https://www.bigmoleculewatch.com/2017/07/31/board-grants-hospira-mixed-results-on-its-five-petitions-for-ipr-of-genentechs-trastuzumab-patents/20%Monthly2018-01-08 18:45
https://www.bigmoleculewatch.com/2017/07/31/sanofi-files-a-second-petition-for-ipr-of-immunexs-dupixent-patent/20%Monthly2018-02-02 16:47
https://www.bigmoleculewatch.com/2017/07/28/update-coherus-motion-to-stay/20%Monthly2018-01-08 18:52
https://www.bigmoleculewatch.com/2017/07/27/white-house-releases-policy-statement-calling-for-elimination-of-federal-funding-for-fdas-pre-market-review-costs/20%Monthly2017-07-31 17:04
https://www.bigmoleculewatch.com/2017/07/27/amgen-v-sandoz-federal-circuit-vacates-opinion-and-mandate-reinstates-appeal-orders-further-briefing-on-remanded-issues/20%Monthly2018-07-25 15:41
https://www.bigmoleculewatch.com/2017/07/26/coherus-requests-stay-of-discovery-in-amgen-v-coherus/20%Monthly2018-01-08 19:04
https://www.bigmoleculewatch.com/2017/07/26/fda-reauthorization-act-of-2017-passes-the-house/20%Monthly2017-07-31 17:06
https://www.bigmoleculewatch.com/2017/07/25/abbvie-v-amgen-adalimumab-reassigned-to-judge-goldberg/20%Monthly2018-07-25 15:45
https://www.bigmoleculewatch.com/2017/07/25/bevacizumab-biosimilar-update/20%Monthly2018-01-08 19:17
https://www.bigmoleculewatch.com/2017/07/24/samsung-bioepis-and-merck-co-launch-renflexis-a-lower-priced-competitor-to-inflectra/20%Monthly2018-01-08 19:18
https://www.bigmoleculewatch.com/2017/07/21/sandoz-files-two-petitions-for-ipr-of-two-abbvie-patents-related-to-humira/20%Monthly2018-01-08 19:19
https://www.bigmoleculewatch.com/2017/07/20/merck-receives-tentative-fda-approval-for-lantus-follow-on/20%Monthly2018-01-08 19:23
https://www.bigmoleculewatch.com/2017/07/19/cms-considers-new-billing-code-policy-for-biosimilars/20%Monthly2017-07-21 13:22
https://www.bigmoleculewatch.com/2017/07/18/fda-committee-recommends-approval-of-bevacizumab-and-trastuzumab-biosimilars/20%Monthly2018-01-08 19:41
https://www.bigmoleculewatch.com/2017/07/17/amgen-withdraws-its-motion-for-preliminary-injunction-against-hospira/20%Monthly2018-01-08 19:41
https://www.bigmoleculewatch.com/2017/07/14/bioverativ-files-itc-complaint-against-csls-idelvion/20%Monthly2018-01-08 19:43
https://www.bigmoleculewatch.com/2017/07/12/hospira-opposes-amgens-pi-motion-in-amgen-v-hospira/20%Monthly2018-07-25 15:46
https://www.bigmoleculewatch.com/2017/07/11/emas-issues-statement-of-non-compliance-for-biocons-biosimilar-manufacturing-facility/20%Monthly2018-01-08 19:46
https://www.bigmoleculewatch.com/2017/07/10/big-molecule-watch-editor-elaine-blais-to-present-during-ipo-ip-chat-channel-webinar/20%Monthly2017-07-10 20:12
https://www.bigmoleculewatch.com/2017/07/07/review-article-supports-interchangeability-of-infliximab-and-ct-p13/20%Monthly2018-01-08 19:48
https://www.bigmoleculewatch.com/2017/07/07/ptab-issues-additional-final-written-decisions-finding-abbvies-humira-patent-unpatentable/20%Monthly2018-01-08 20:11
https://www.bigmoleculewatch.com/2017/07/06/biocad-announces-impending-approval-of-its-rituximab-biosimilar-in-india/20%Monthly2018-01-08 20:12
https://www.bigmoleculewatch.com/2017/07/06/pfizer-files-two-petitions-for-ipr-of-genentechs-trastuzumab-patent/20%Monthly2018-01-08 21:36
https://www.bigmoleculewatch.com/2017/07/05/coherus-implements-restructuring-plan-following-complete-response-letter-for-its-pegfilgrastim-biosimilar/20%Monthly2018-01-08 21:37
https://www.bigmoleculewatch.com/2017/07/05/discontinuation-of-etanercept-biosimilar-in-japan/20%Monthly2018-01-08 21:39